109
Participants
Start Date
August 1, 2016
Primary Completion Date
July 31, 2024
Study Completion Date
August 31, 2026
Vinblastine
Bevacizumab
The Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta, Atlanta
Children's Hospital Colorado, Aurora
Children's Hospital Los Angeles, Los Angeles
Children's Hospital at Westmead, Westmead
Queensland Children's Hospital, South Brisbane
Women's and Children's Hospital, North Adelaide
Royal Children's Hospital, Parkville
Perth Children's Hospital, Nedlands
Alberta Children's Hospital, Calgary
Stollery Children's Hospital, Edmonton
BC Children's Hospital, Vancouver
Cancer Care Manitoba, Winnipeg
McMaster Children's Hospital, Hamilton
Children's Hospital - London Health Sciences Centre, London
Centre Hospitalier Universitaire Sainte-Justine, Montreal
Montreal Children's Hospital, Montreal
CHU du Quebec-Universite Laval, Québec
Starship Children's Hospital, Grafton
The Hospital for Sick Children, Toronto
Hoffmann-La Roche
INDUSTRY
The Hospital for Sick Children
OTHER